Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marin Kollef, M.D.
Washington University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Limoges, Limousin, France
- Facility name not stated
Orléans, Loiret, France
- Facility name not stated
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
- Facility name not stated
Colombes, Île-de-France Region, France
- Facility name not stated
Tours, France
- Facility name not stated
Alexandroupoli, Evros, Greece
- Facility name not stated
Athens, Greece
- Facility name not stated
Athens, Greece
- Facility name not stated
Athens, Greece
- Facility name not stated
Athens, Greece
- Facility name not stated
Ioannina, Greece
- Facility name not stated
Larissa, Greece
- Facility name not stated
Debrecen, Hajdú-Bihar, Hungary
- Facility name not stated
Debrecen, Hajdú-Bihar, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
San Juan, Puerto Rico
- Facility name not stated
Palma de Majorca, Balearic Islands, Spain
- Facility name not stated
Getafe, Madrid, Spain
- Facility name not stated
Barcelona, Spain
- Facility name not stated
Ankara, Ankara, Turkey (Türkiye)
- Facility name not stated
Ankara, Turkey (Türkiye)
- Facility name not stated
Istanbul, Turkey (Türkiye)
- Facility name not stated
Istanbul, Turkey (Türkiye)
- Facility name not stated
Trabzon, Turkey (Türkiye)
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Gainesville, Florida, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Hazard, Kentucky, United States
- Facility name not stated
Lexington, Kentucky, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Burlington, Massachusetts, United States
- Facility name not stated
Springfield, Massachusetts, United States
- Facility name not stated
Detroit, Michigan, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Omaha, Nebraska, United States
- Facility name not stated
Oklahoma City, Oklahoma, United States
- Facility name not stated
Knoxville, Tennessee, United States
- Facility name not stated
El Paso, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2013
- Primary completion
- 31 Mar 2016
- Completion
- 30 Apr 2016
- Last update posted
- 2 Jul 2017
- Registered enrollment
- 143
- Registry id
- NCT01969799
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.